BIOQUÍMICA Y BIOLOGÍA MOLECULAR III E INMUNOLOGÍA
DEPARTAMENTO
Leiden University Medical Center
Leiden, HolandaPublicaciones en colaboración con investigadores/as de Leiden University Medical Center (9)
2023
-
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
The Lancet, Vol. 401, Núm. 10374, pp. 347-356
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi
Molecular Therapy Nucleic Acids, Vol. 34
2017
-
Increased expression of microRNA-155 in peripheral blood mononuclear cells from psoriasis patients is related to disease activity
Journal of the European Academy of Dermatology and Venereology, Vol. 31, Núm. 2, pp. 312-322
2016
-
The urgent need to recover MHC class I in cancers for effective immunotherapy
Current Opinion in Immunology, Vol. 39, pp. 44-51
2010
-
Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: A meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four european populations
Arthritis and Rheumatism, Vol. 62, Núm. 5, pp. 1236-1245
2005
-
Analysis of a Functional BTNL2 Polymorphism in Type 1 Diabetes, Rheumatoid Arthritis, and Systemic Lupus Erythematosus
Human Immunology, Vol. 66, Núm. 12, pp. 1235-1241
2002
-
Genetic determinants of rheumatoid arthritis: The inducible nitric oxide synthase (NOS2) gene promoter polymorphism
Genes and Immunity, Vol. 3, Núm. 5, pp. 299-301
2001
-
Rheumatoid arthritis in southern Spain: Toward elucidation of a unifying role of the HLA class II region in disease predisposition
Arthritis and Rheumatism, Vol. 44, Núm. 2, pp. 307-314